Prosecution Insights
Last updated: October 02, 2026
Application No. 19/078,626

TRIGGERING VIRTUAL CLINICAL EXAMS

Non-Final OA §101§102§DOUBLEPATENT
Filed
Mar 13, 2025
Priority
Oct 12, 2020 — provisional 63/198,335 +1 more
Examiner
LONG, MEREDITH A
Art Unit
Tech Center
Assignee
Verily Life Sciences LLC
OA Round
1 (Non-Final)
43%
Grant Probability
Moderate
1-2
OA Rounds
1y 9m
Est. Remaining
64%
With Interview

Examiner Intelligence

Grants 43% of resolved cases
43%
Career Allowance Rate
182 granted / 421 resolved
-16.8% vs TC avg
Strong +21% interview lift
Without
With
+21.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
22 currently pending
Career history
447
Total Applications
across all art units

Statute-Specific Performance

§101
37.9%
-2.1% vs TC avg
§103
31.4%
-8.6% vs TC avg
§102
12.2%
-27.8% vs TC avg
§112
14.1%
-25.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 421 resolved cases

Office Action

§101 §102 §DOUBLEPATENT
DETAILED ACTION This communication is in response to application no. 19/078626 filed 13 March 2025. Claims 1-20 are currently pending and have been examined. Claims 1-20 are rejected as shown in this detailed action. Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-20 are rejected under 35 U.S.C. 101 because the claimed invention is directed to a judicial exception (i.e., a law of nature, a natural phenomenon, or an abstract idea) without significantly more. Step 1 Claims 1-9 recite a method which is considered a process. Claims 10-18 recite a non-transitory computer-readable medium which is considered a machine or manufacture. Claims 19 and 20 recite a server computer which is considered a machine or manufacture. Step 2A-Prong One (Claims 1, 10, and 19) The “determining one or more conditions for triggering presentation of a particular type of virtual clinical exam based at least in part on the exam information and the dynamic sensor data” step, as drafted, is a process that under its broadest reasonable interpretation, covers performance of the limitation in the mind but for the recitation of generic computer components. For example, but for the “computer-implemented” language in claim 1, the “cause one or more processors to” language in claim 10, or the “cause the server computer to perform” language in claim 19, the claim encompasses a user manually using given information to make a determination. These claims fall into the mental processes grouping of abstract ideas and thus recite an abstract idea. (Claims 2 and 11) These claims recite use of a machine learning model into which data is fed and used to assist in the “determining” step (see “training a machine-learning model using the exam information and the dynamic sensor data as inputs to the machine-learning model, and determining the one or more conditions based at least in part on the machine-learning model” in claim 2). The model is not defined in the specification in any detail other than by its inputs (i.e., the exam information and the dynamic sensor data) and its outputs (i.e., the one or more conditions). Thus, the use of this model does not take the claims out of the above-identified abstract idea grouping. These claims recite an abstract idea. (Claims 3 and 12) The “updating the one or more conditions based at least in part on the updated exam information and the updated dynamic sensor data” step, as drafted, is a process that under its broadest reasonable interpretation, covers performance of the limitation in the mind but for the recitation of generic computer components. For example, but for the “computer-implemented” language in claim 3 or the “cause one or more processors to” language in claim 12, the claim encompasses a user manually using given information to update determined conditions. These claims fall into the mental processes grouping of abstract ideas and thus recite an abstract idea. (Claims 4, 5, 13, 14, and 20) These claims further define the received data (see “the dynamic sensor data comprise raw sensor data” in claim 4 and “the exam information identifies at least beginning times and ending times for the plurality of virtual clinical exams” in claim 5). These limitations do not take the claims out of the above-identified abstract idea grouping. Thus, these claims recite an abstract idea. (Claims 6, 15, and 20) These claims further define information related to the received data (see “the plurality of virtual clinical exams are tailored to one or more movement disorders” in claim 6). These limitations do not take the claims out of the above-identified abstract idea grouping. Thus, these claims recite an abstract idea. (Claims 7 and 16) The “wherein determining the one or more conditions comprises determining the one or more conditions based at least in part on the static data” step, as drafted, is a process that under its broadest reasonable interpretation, covers performance of the limitation in the mind but for the recitation of generic computer components. For example, but for the “computer-implemented” language in claim 7 or the “cause one or more processors to” language in claim 16, the claim encompasses a user manually using given information to make a determination. These claims fall into the mental processes grouping of abstract ideas and thus recite an abstract idea. (Claims 8 and 17) The “wherein determining the one or more conditions comprises determining the one or more conditions based at least in part on the user profile information” step, as drafted, is a process that under its broadest reasonable interpretation, covers performance of the limitation in the mind but for the recitation of generic computer components. For example, but for the “computer-implemented” language in claim 8 or the “cause one or more processors to” language in claim 17, the claim encompasses a user manually using given information to make a determination. These claims fall into the mental processes grouping of abstract ideas and thus recite an abstract idea. (Claims 9, 18, and 20) These claims further define what is determined in the “determining” steps (see “the one or more conditions define one or more value ranges for the dynamic sensor data” in claim 9). These limitations are not so complex that they could not be performed in the mind; a human can determine value ranges. Thus, these limitations do not take the claims out of the above-identified abstract idea grouping. These claims recite an abstract idea. Step 2A-Prong Two This judicial exception is not integrated into a practical application. The claims recite the additional element of a computer (found in claims 1-9), a non-transitory computer-readable medium and a processor (found in claims 10-18), or a server computer comprising memory (found in claims 19 and 20) and includes no more than mere instructions to apply the exception using a generic computer component. The computer, computer-readable medium, or server computer does not integrate the abstract idea into a practical application because it does not impose any meaningful limits on practicing the abstract idea. Additionally, the steps of “receiving, from a plurality of user devices, exam information corresponding to a plurality of virtual clinical exams performed by the plurality of user devices, the exam information identifying at least a virtual clinical exam type for each of the plurality of virtual clinical exams” (found in claims 1, 10, and 19), “receiving, from the plurality of user devices, dynamic sensor data corresponding to the plurality of virtual clinical exams, the dynamic sensor data collected by one or more sensors associated with the plurality of user devices” (found in claims 1, 10, and 19), “receiving updated exam information associated with presentation of the particular type of virtual clinical exam at the particular user device” (found in claims 3 and 12), “receiving updated dynamic sensor data associated with presentation of the particular type of virtual clinical exam at the particular user device” (found in claims 3 and 12), “receiving static data comprising at least health record data or demographic data” (found in claims 7 and 16), and “receiving user profile information corresponding to a particular user profile that is associated with the particular user device” (found in claims 8 and 17) are mere data gathering and the step of “providing the one or more conditions to a particular user device for use by the particular user device in triggering presentation of the particular type of virtual clinical exam at the particular user device” (found in claims 1, 10, and 10) is post-solution activity. These steps are considered insignificant extra-solution activity and do not integrate the abstract idea into a practical application. Note that the phrase “for use by the particular user device in triggering presentation of the particular type of virtual clinical exam at the particular user device” in interpreted to be intended use and is not given patentable weight. Step 2B The claims do not include additional elements that are sufficient to amount to significantly more than the judicial exception. As discussed previously with respect to Step 2A-Prong Two, the additional element in the claim amounts to no more than mere instructions to apply the exception using a generic computer component. The same analysis applies here in Step 2B, i.e., mere instructions to apply an exception using a generic computer component cannot integrate a judicial exception into a practical application at Step 2A or provide an inventive concept in Step 2B. See MPEP 2106.05(f). The claims do not provide an inventive concept (significantly more than the abstract idea). The claims are ineligible. The courts have recognized that when certain functions are claimed in a merely generic manner, they are well-understood, routine, and conventional. This includes the above-identified “receiving” and “providing” steps, which fall under the recognized function of “Receiving or transmitting data over a network, e.g., using the Internet to gather data.” See MPEP 2106.05(d)(II). Thus, these steps do not contribute an “inventive concept” under Step 2B analysis. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claim 1 is rejected on the ground of nonstatutory double patenting as being unpatentable over claim 10 of U.S. Patent No. 12,278,002. Although the claims at issue are not identical, they are not patentably distinct from each other because the claim under examination is anticipated by the patented claim. Claim 3 is rejected on the ground of nonstatutory double patenting as being unpatentable over claim 10 of U.S. Patent No. 12,278,002. Although the claims at issue are not identical, they are not patentably distinct from each other because the claim under examination is anticipated by the patented claim. Claim 4 is rejected on the ground of nonstatutory double patenting as being unpatentable over claim 10 of U.S. Patent No. 12,278,002. Although the claims at issue are not identical, they are not patentably distinct from each other because the claim under examination is anticipated by the patented claim. Claim 6 is rejected on the ground of nonstatutory double patenting as being unpatentable over claim 11 of U.S. Patent No. 12,278,002. Although the claims at issue are not identical, they are not patentably distinct from each other because the claim under examination is anticipated by the patented claim. Claim 7 is rejected on the ground of nonstatutory double patenting as being unpatentable over claim 15 of U.S. Patent No. 12,278,002. Although the claims at issue are not identical, they are not patentably distinct from each other because the claim under examination is anticipated by the patented claim. Claim 8 is rejected on the ground of nonstatutory double patenting as being unpatentable over claim 15 of U.S. Patent No. 12,278,002. Although the claims at issue are not identical, they are not patentably distinct from each other because the claim under examination is anticipated by the patented claim. Claim 9 is rejected on the ground of nonstatutory double patenting as being unpatentable over claim 12 of U.S. Patent No. 12,278,002. Although the claims at issue are not identical, they are not patentably distinct from each other because the claim under examination is anticipated by the patented claim. Claim 10 is rejected on the ground of nonstatutory double patenting as being unpatentable over claim 10 of U.S. Patent No. 12,278,002. Although the claims at issue are not identical, they are not patentably distinct from each other because the claim under examination is anticipated by the patented claim. Claim 12 is rejected on the ground of nonstatutory double patenting as being unpatentable over claim 10 of U.S. Patent No. 12,278,002. Although the claims at issue are not identical, they are not patentably distinct from each other because the claim under examination is anticipated by the patented claim. Claim 13 is rejected on the ground of nonstatutory double patenting as being unpatentable over claim 10 of U.S. Patent No. 12,278,002. Although the claims at issue are not identical, they are not patentably distinct from each other because the claim under examination is anticipated by the patented claim. Claim 15 is rejected on the ground of nonstatutory double patenting as being unpatentable over claim 11 of U.S. Patent No. 12,278,002. Although the claims at issue are not identical, they are not patentably distinct from each other because the claim under examination is anticipated by the patented claim. Claim 16 is rejected on the ground of nonstatutory double patenting as being unpatentable over claim 11 of U.S. Patent No. 12,278,002. Although the claims at issue are not identical, they are not patentably distinct from each other because the claim under examination is anticipated by the patented claim. Claim 17 is rejected on the ground of nonstatutory double patenting as being unpatentable over claim 11 of U.S. Patent No. 12,278,002. Although the claims at issue are not identical, they are not patentably distinct from each other because the claim under examination is anticipated by the patented claim. Claim 18 is rejected on the ground of nonstatutory double patenting as being unpatentable over claim 12 of U.S. Patent No. 12,278,002. Although the claims at issue are not identical, they are not patentably distinct from each other because the claim under examination is anticipated by the patented claim. Claim 19 is rejected on the ground of nonstatutory double patenting as being unpatentable over claim 10 of U.S. Patent No. 12,278,002. Although the claims at issue are not identical, they are not patentably distinct from each other because the claim under examination is anticipated by the patented claim. Conclusion The claims are not rejected under 35 USC § 102/103. While virtual clinical exams are known in the art (See US 2023/0335274 (“Bychkov”) at [0017] “there is provided a method for performing one or more remote medical examinations of a patient, the method comprises performing the following for at least one remote medical examination of the remote medical examinations: receiving, by a processing resource, during the remote medical examination, from a remote medical data acquisition device, first data generated from medical data acquired by a sensor of the remote medical data acquisition device from a body of the patient” and US 2020/0381119 (“Gibbs”) at [0010] “proactive telemedicine system therefore provides the pet health data necessary for improving a veterinarian's virtual examination of the pet.”), determining conditions for triggering a particular virtual clinical exam based on 1) exam information corresponding to a plurality of virtual clinical exams performed by a plurality of user devices, the exam information identifying at least a virtual exam type, and 2) dynamic sensor data corresponding to the plurality of virtual clinical exams is not found in the prior art. Bychkov is considered the closest prior art. Cireddu, Nasry, and Singh, cited in the parent application (17/450521), also remain relevant as they all disclose virtual clinical exams. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MEREDITH A LONG whose telephone number is (571)272-3196. The examiner can normally be reached Mon - Fri 9:30 - 6. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Ilana Spar can be reached on 571-270-7537. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MEREDITH A LONG/Primary Examiner, Art Unit 3622
Read full office action

Prosecution Timeline

Mar 13, 2025
Application Filed
Sep 09, 2026
Non-Final Rejection mailed — §101, §102, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12725186
COMPUTER-BASED IDENTIFICATION AND PRESENTATION OF VIRTUAL WORLD ADVERTISEMENTS
3y 5m to grant Granted Sep 01, 2026
Patent 12718218
TRANSACTION SYSTEM, TRANSACTION APPARATUS, AND TRANSACTION METHOD
1y 7m to grant Granted Aug 25, 2026
Patent 12700018
Preservation of Scores of the Quality of Traffic to Network Sites Across Clients and Over Time
1y 6m to grant Granted Aug 04, 2026
Patent 12682376
STATIC AND DYNAMIC NETWORK DEVICE AND SERVICE INVENTORIES AS A MECHANISM TO GENERATE PERSONALIZED AD PROFILES
2y 1m to grant Granted Jul 14, 2026
Patent 12626274
MANAGEMENT OF MOVING OUTDOOR ADVERTISING
1y 5m to grant Granted May 12, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
43%
Grant Probability
64%
With Interview (+21.1%)
3y 3m (~1y 9m remaining)
Median Time to Grant
Low
PTA Risk
Based on 421 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month